talazoparib,enzalutamide
astellas,pfizer
['gu ', 'talapro-2', 'crpc', 'talazo']
just presented at asco gu 2023! - : talazoparib plus enza vs enza resulted in improvement in pfs as 1l treatment in pts with mcrpc regardless of hrr status.
#ascogu23 
A dedicated conference for oncology held under the theme "Access. Educate. Collaborate"